Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.
Identifieur interne : 005563 ( PubMed/Checkpoint ); précédent : 005562; suivant : 005564Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.
Auteurs : J V Fiorica ; W S Roberts ; H. Greenberg ; M S Hoffman ; J P Lapolla ; D. CavanaghSource :
- Gynecologic oncology [ 0090-8258 ] ; 1990.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Adénocarcinome (), Adénocarcinome (radiothérapie), Analyse de survie, Carcinome épidermoïde (), Carcinome épidermoïde (radiothérapie), Femelle, Humains, Hystérectomie, Lésions radio-induites (anatomopathologie), Maladies gastro-intestinales (étiologie), Récidive tumorale locale, Sujet âgé, Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (radiothérapie).
- MESH :
- anatomopathologie : Lésions radio-induites.
- radiothérapie : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- étiologie : Maladies gastro-intestinales.
- Adulte, Adulte d'âge moyen, Adénocarcinome, Analyse de survie, Carcinome épidermoïde, Femelle, Humains, Hystérectomie, Récidive tumorale locale, Sujet âgé, Tumeurs du col de l'utérus.
English descriptors
- KwdEn :
- Adenocarcinoma (radiotherapy), Adenocarcinoma (surgery), Adenocarcinoma (therapy), Adult, Aged, Carcinoma, Squamous Cell (radiotherapy), Carcinoma, Squamous Cell (surgery), Carcinoma, Squamous Cell (therapy), Female, Gastrointestinal Diseases (etiology), Humans, Hysterectomy, Middle Aged, Neoplasm Recurrence, Local, Radiation Injuries (pathology), Survival Analysis, Uterine Cervical Neoplasms (radiotherapy), Uterine Cervical Neoplasms (surgery), Uterine Cervical Neoplasms (therapy).
- MESH :
- etiology : Gastrointestinal Diseases.
- pathology : Radiation Injuries.
- radiotherapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- surgery : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- therapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- Adult, Aged, Female, Humans, Hysterectomy, Middle Aged, Neoplasm Recurrence, Local, Survival Analysis.
Abstract
Morbidity and survival patterns were reviewed in 50 patients who underwent radical hysterectomy, pelvic lymphadenectomy, and adjuvant postoperative pelvic radiotherapy for invasive cervical cancer. Ninety percent of the patients were FIGO stage IB, and 10% were clinical stage IIA or IIB. Indications for adjuvant radiotherapy included pelvic lymph node metastasis, large volume, deep stromal penetration, lower uterine segment involvement, or capillary space involvement. Seventy-two percent of the patients had multiple high-risk factors. An average of 4700 cGy of whole-pelvis radiotherapy was administered. Ten percent of the patients suffered major gastrointestinal complications, 14% minor gastrointestinal morbidity, 12% minor genitourinary complications, one patient a lymphocyst, and one patient lymphedema. Of the five patients with major gastrointestinal morbidity, all occurred within 12 months of treatment. Three patients required intestinal bypass surgery for distal ileal obstructions and all are currently doing well and free of disease. All of the patients who developed recurrent disease had multiple, high-risk factors. The median time of recurrence was 12 months. All patients recurred within the radiated field. Actuarial survival was 90% and disease-free survival 87% at 70 months. It is our opinion that the morbidity of postoperative pelvic radiotherapy is acceptable, and benefit may be gained in such a high-risk patient population.
PubMed: 2318443
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:2318443Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.</title><author><name sortKey="Fiorica, J V" sort="Fiorica, J V" uniqKey="Fiorica J" first="J V" last="Fiorica">J V Fiorica</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33612.</nlm:affiliation><wicri:noCountry code="subField">Tampa 33612</wicri:noCountry></affiliation></author><author><name sortKey="Roberts, W S" sort="Roberts, W S" uniqKey="Roberts W" first="W S" last="Roberts">W S Roberts</name></author><author><name sortKey="Greenberg, H" sort="Greenberg, H" uniqKey="Greenberg H" first="H" last="Greenberg">H. Greenberg</name></author><author><name sortKey="Hoffman, M S" sort="Hoffman, M S" uniqKey="Hoffman M" first="M S" last="Hoffman">M S Hoffman</name></author><author><name sortKey="Lapolla, J P" sort="Lapolla, J P" uniqKey="Lapolla J" first="J P" last="Lapolla">J P Lapolla</name></author><author><name sortKey="Cavanagh, D" sort="Cavanagh, D" uniqKey="Cavanagh D" first="D" last="Cavanagh">D. Cavanagh</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1990">1990</date><idno type="RBID">pubmed:2318443</idno><idno type="pmid">2318443</idno><idno type="wicri:Area/PubMed/Corpus">005E00</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005E00</idno><idno type="wicri:Area/PubMed/Curation">005E00</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005E00</idno><idno type="wicri:Area/PubMed/Checkpoint">005E00</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005E00</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.</title><author><name sortKey="Fiorica, J V" sort="Fiorica, J V" uniqKey="Fiorica J" first="J V" last="Fiorica">J V Fiorica</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33612.</nlm:affiliation><wicri:noCountry code="subField">Tampa 33612</wicri:noCountry></affiliation></author><author><name sortKey="Roberts, W S" sort="Roberts, W S" uniqKey="Roberts W" first="W S" last="Roberts">W S Roberts</name></author><author><name sortKey="Greenberg, H" sort="Greenberg, H" uniqKey="Greenberg H" first="H" last="Greenberg">H. Greenberg</name></author><author><name sortKey="Hoffman, M S" sort="Hoffman, M S" uniqKey="Hoffman M" first="M S" last="Hoffman">M S Hoffman</name></author><author><name sortKey="Lapolla, J P" sort="Lapolla, J P" uniqKey="Lapolla J" first="J P" last="Lapolla">J P Lapolla</name></author><author><name sortKey="Cavanagh, D" sort="Cavanagh, D" uniqKey="Cavanagh D" first="D" last="Cavanagh">D. Cavanagh</name></author></analytic><series><title level="j">Gynecologic oncology</title><idno type="ISSN">0090-8258</idno><imprint><date when="1990" type="published">1990</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (radiotherapy)</term><term>Adenocarcinoma (surgery)</term><term>Adenocarcinoma (therapy)</term><term>Adult</term><term>Aged</term><term>Carcinoma, Squamous Cell (radiotherapy)</term><term>Carcinoma, Squamous Cell (surgery)</term><term>Carcinoma, Squamous Cell (therapy)</term><term>Female</term><term>Gastrointestinal Diseases (etiology)</term><term>Humans</term><term>Hysterectomy</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Radiation Injuries (pathology)</term><term>Survival Analysis</term><term>Uterine Cervical Neoplasms (radiotherapy)</term><term>Uterine Cervical Neoplasms (surgery)</term><term>Uterine Cervical Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Adénocarcinome ()</term><term>Adénocarcinome (radiothérapie)</term><term>Analyse de survie</term><term>Carcinome épidermoïde ()</term><term>Carcinome épidermoïde (radiothérapie)</term><term>Femelle</term><term>Humains</term><term>Hystérectomie</term><term>Lésions radio-induites (anatomopathologie)</term><term>Maladies gastro-intestinales (étiologie)</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Tumeurs du col de l'utérus ()</term><term>Tumeurs du col de l'utérus (radiothérapie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lésions radio-induites</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Gastrointestinal Diseases</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Radiation Injuries</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Adénocarcinome</term><term>Carcinome épidermoïde</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Maladies gastro-intestinales</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Survival Analysis</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Adénocarcinome</term><term>Analyse de survie</term><term>Carcinome épidermoïde</term><term>Femelle</term><term>Humains</term><term>Hystérectomie</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Tumeurs du col de l'utérus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Morbidity and survival patterns were reviewed in 50 patients who underwent radical hysterectomy, pelvic lymphadenectomy, and adjuvant postoperative pelvic radiotherapy for invasive cervical cancer. Ninety percent of the patients were FIGO stage IB, and 10% were clinical stage IIA or IIB. Indications for adjuvant radiotherapy included pelvic lymph node metastasis, large volume, deep stromal penetration, lower uterine segment involvement, or capillary space involvement. Seventy-two percent of the patients had multiple high-risk factors. An average of 4700 cGy of whole-pelvis radiotherapy was administered. Ten percent of the patients suffered major gastrointestinal complications, 14% minor gastrointestinal morbidity, 12% minor genitourinary complications, one patient a lymphocyst, and one patient lymphedema. Of the five patients with major gastrointestinal morbidity, all occurred within 12 months of treatment. Three patients required intestinal bypass surgery for distal ileal obstructions and all are currently doing well and free of disease. All of the patients who developed recurrent disease had multiple, high-risk factors. The median time of recurrence was 12 months. All patients recurred within the radiated field. Actuarial survival was 90% and disease-free survival 87% at 70 months. It is our opinion that the morbidity of postoperative pelvic radiotherapy is acceptable, and benefit may be gained in such a high-risk patient population.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2318443</PMID><DateCreated><Year>1990</Year><Month>05</Month><Day>07</Day></DateCreated><DateCompleted><Year>1990</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0090-8258</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>1990</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Gynecologic oncology</Title><ISOAbbreviation>Gynecol. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.</ArticleTitle><Pagination><MedlinePgn>343-7</MedlinePgn></Pagination><Abstract><AbstractText>Morbidity and survival patterns were reviewed in 50 patients who underwent radical hysterectomy, pelvic lymphadenectomy, and adjuvant postoperative pelvic radiotherapy for invasive cervical cancer. Ninety percent of the patients were FIGO stage IB, and 10% were clinical stage IIA or IIB. Indications for adjuvant radiotherapy included pelvic lymph node metastasis, large volume, deep stromal penetration, lower uterine segment involvement, or capillary space involvement. Seventy-two percent of the patients had multiple high-risk factors. An average of 4700 cGy of whole-pelvis radiotherapy was administered. Ten percent of the patients suffered major gastrointestinal complications, 14% minor gastrointestinal morbidity, 12% minor genitourinary complications, one patient a lymphocyst, and one patient lymphedema. Of the five patients with major gastrointestinal morbidity, all occurred within 12 months of treatment. Three patients required intestinal bypass surgery for distal ileal obstructions and all are currently doing well and free of disease. All of the patients who developed recurrent disease had multiple, high-risk factors. The median time of recurrence was 12 months. All patients recurred within the radiated field. Actuarial survival was 90% and disease-free survival 87% at 70 months. It is our opinion that the morbidity of postoperative pelvic radiotherapy is acceptable, and benefit may be gained in such a high-risk patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fiorica</LastName><ForeName>J V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33612.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>W S</ForeName><Initials>WS</Initials></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>LaPolla</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Cavanagh</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gynecol Oncol</MedlineTA><NlmUniqueID>0365304</NlmUniqueID><ISSNLinking>0090-8258</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007044" MajorTopicYN="N">Hysterectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011832" MajorTopicYN="N">Radiation Injuries</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2318443</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Cavanagh, D" sort="Cavanagh, D" uniqKey="Cavanagh D" first="D" last="Cavanagh">D. Cavanagh</name><name sortKey="Fiorica, J V" sort="Fiorica, J V" uniqKey="Fiorica J" first="J V" last="Fiorica">J V Fiorica</name><name sortKey="Greenberg, H" sort="Greenberg, H" uniqKey="Greenberg H" first="H" last="Greenberg">H. Greenberg</name><name sortKey="Hoffman, M S" sort="Hoffman, M S" uniqKey="Hoffman M" first="M S" last="Hoffman">M S Hoffman</name><name sortKey="Lapolla, J P" sort="Lapolla, J P" uniqKey="Lapolla J" first="J P" last="Lapolla">J P Lapolla</name><name sortKey="Roberts, W S" sort="Roberts, W S" uniqKey="Roberts W" first="W S" last="Roberts">W S Roberts</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005563 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 005563 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:2318443
|texte= Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:2318443" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |